Baidu
map

Comparative Safety, Efficacy and Survival Outcome of Anti-PD-1 Immunotherapy in Colorectal Cancer Patients With vs Without Hepatitis B Virus Infection: A Multicenter Cohort Study

Cheng, YK; Chen, P; Chen, DW; Lin, ZS; Ye, SB; Lan, P

Chen, P (通讯作者),State Key Lab Oncol South China, Guangzhou, Peoples R China.;Ye, SB (通讯作者),Sun Yat Sen Univ, Affiliated Hosp 6, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China.;Ye, SB (通讯作者),Guangdong Inst Gastroenterol, Guangzhou, Guangdong, Peoples R China.;Ye, SB (通讯作者),Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou, Guangdong, Peoples R China.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2022; 13 (5):

Abstract

INTRODUCTION: Antiprogrammed cell death protein-1 (PD-1) immunotherapy has substantially broadened in scope for the treatment of colorectal cancer (CR......

Full Text Link


Baidu
map
Baidu
map
Baidu
map